Sabatolimab Active Not Recruiting Phase 1 Trials for Glioblastoma Multiforme (GBM) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03961971Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM